Israel Active

An international clinical intervention study led by Ben-Gurion University researchers showed that the Green-MED diet - polyphenol-rich that includes green tea, walnuts, and the aquatic plant (Wolffia globosa), benefits insulin sensitivity and reduces inflammation, triglycerides and fats.

Researchers from Ben-Gurion University have found that the speed that an older adult can execute a voluntary step (especially when distracted by a concurrently performed cognitive task) may serve as a valuable clinical predictor of longevity. The test measures neuromuscular and cognitive vitality.

This work began some years ago (see previously). Researchers from Tel Aviv University and Sheba Medical Center have developed an artificial intelligence-based system that can detect anemia and estimate key blood markers using a brief video scan of blood vessels in the eye.

Scientists at Israel’s Technion scientists have found that bacteria can rapidly create dozens of copies of specific genes that help them survive antibiotics. The discovery it could pave the way for medication designed to disrupt the mechanism and improve the effectiveness of antibiotics.

Tel Aviv University researchers have developed one of the first experimental models for eosinophilic gastritis - an allergic disease of the stomach. The model helped identify the immune pathways responsible the disease and has led to a new generation of biologic therapies.

Researchers at Israel’s Technion have uncovered a natural mechanism through which the body repairs itself. Contrary to what was previously believed, mature, aged cells retain the ability to “turn back time” and revert into active stem cells that regenerate damaged tissue.

Researchers from Ben-Gurion University and Stanford University have discovered a completely unknown type of immune cell in flatworms that protects the body by literally erupting. The newly identified cells, named ruptoblasts, sense a hormone spike and erupt, destroying invading microbes.

Scientists from Israel’s Technion Institute have engineered MPsomes – nanoparticles that block macrophages that provide tumors with food. It gives hope to patients with aggressive triple-negative breast cancer, which accounts for 40% of deaths and cannot be treated with conventional hormone therapy.

Scientists at Israel’s Weizmann Institute have paved the way for a vaccine against ovarian cancer. It utilizes “memory B cells”, rather than T cells, to tag the cancer as a target and produce antibodies that specifically recognize and target ovarian cancer cells.

Mexico’s Jusidman is donating NIS 200 million toward a new $390 million rehabilitation center in Sde Dov. It will include some 540 inpatient beds, a trauma clinic, an imaging institute, a hydrotherapy pool, advanced rehabilitation, an R&D incubator, and a green environment.